INTS vs XOM
Intensity Therapeutics, Inc. Common stock (INTS) versus Exxon Mobil Corp (XOM) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Exxon Mobil Corp (XOM) is a oil & gas integrated company listed on NYSE. It is led by Darren Woods.
INTS does not have a complete income-statement cache yet.
Latest reported XOM revenue for 2025-12-31 was $332.24B. Net income was $28.84B. Revenue was down 5.0% from 2024-12-31 to 2025-12-31. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
INTS currently screens at market cap $7.7M. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
Not investment advice. Open the INTS and XOM stock pages for the full models.
Not investment advice.